301246 宏源药业
已收盘 03-27 15:00:00
资讯
新帖
简况
宏源药业：6000吨/年产高纯晶体六氟磷酸锂改扩建项目正在建设中
证券之星 · 03-26
宏源药业：6000吨/年产高纯晶体六氟磷酸锂改扩建项目正在建设中
宏源药业（301246）1062.88万股限售股将于3月20日解禁，占总股本2.66%
证券之星 · 03-20
宏源药业（301246）1062.88万股限售股将于3月20日解禁，占总股本2.66%
宏源药业（301246）披露首次公开发行前部分股份上市流通提示性公告，3月17日股价下跌3.76%
证券之星 · 03-17
宏源药业（301246）披露首次公开发行前部分股份上市流通提示性公告，3月17日股价下跌3.76%
宏源药业（301246）披露关于使用部分超募资金及闲置募集资金进行现金管理的公告，3月13日股价下跌1.0%
证券之星 · 03-13
宏源药业（301246）披露关于使用部分超募资金及闲置募集资金进行现金管理的公告，3月13日股价下跌1.0%
宏源药业（301246）披露控股股东、实际控制人续签一致行动协议公告，3月11日股价上涨2.92%
证券之星 · 03-11
宏源药业（301246）披露控股股东、实际控制人续签一致行动协议公告，3月11日股价上涨2.92%
宏源药业：公司的六氟磷酸锂产品生产经营正常
证券之星 · 03-06
宏源药业：公司的六氟磷酸锂产品生产经营正常
股市必读：宏源药业（301246）今年截至3月3日累计跌幅已超20%
证券之星 · 03-04
股市必读：宏源药业（301246）今年截至3月3日累计跌幅已超20%
宏源药业跌2.66% 2023年上市即巅峰超募15亿
中金财经 · 02-12
宏源药业跌2.66% 2023年上市即巅峰超募15亿
宏源药业：目前公司现有六氟磷酸钠产品设计产能400吨/年
证券之星 · 02-06
宏源药业：目前公司现有六氟磷酸钠产品设计产能400吨/年
股市必读：宏源药业（301246）2月4日董秘有最新回复
证券之星 · 02-05
股市必读：宏源药业（301246）2月4日董秘有最新回复
宏源药业：年产7000吨VC添加剂项目正处于建设中
证券之星 · 02-04
宏源药业：年产7000吨VC添加剂项目正处于建设中
宏源药业：六氟磷酸钠是钠电池的核心原材料
证券之星 · 02-03
宏源药业：六氟磷酸钠是钠电池的核心原材料
宏源药业（301246）披露关于变更签字注册会计师的公告，01月20日股价下跌3.87%
证券之星 · 01-20
宏源药业（301246）披露关于变更签字注册会计师的公告，01月20日股价下跌3.87%
股市必读：宏源药业（301246）预计2025年全年归属净利润盈利1.13亿元至1.37亿元
证券之星 · 01-19
股市必读：宏源药业（301246）预计2025年全年归属净利润盈利1.13亿元至1.37亿元
宏源药业(301246.SZ)发预增，预计2025年度归母净利润同比增长119.57%-166.20%
智通财经 · 01-16
宏源药业(301246.SZ)发预增，预计2025年度归母净利润同比增长119.57%-166.20%
宏源药业跌4.44% 2023年上市即巅峰超募15亿
中金财经 · 01-06
宏源药业跌4.44% 2023年上市即巅峰超募15亿
每周股票复盘：宏源药业（301246）因换手率上榜龙虎榜
证券之星 · 01-03
每周股票复盘：宏源药业（301246）因换手率上榜龙虎榜
12月29日宏源药业（301246）龙虎榜数据：游资章盟主上榜
证券之星 · 2025-12-29
12月29日宏源药业（301246）龙虎榜数据：游资章盟主上榜
宏源药业跌10.97% 2023年上市即巅峰超募15亿
中金财经 · 2025-12-29
宏源药业跌10.97% 2023年上市即巅峰超募15亿
12月26日宏源药业（301246）龙虎榜数据：游资章盟主上榜
证券之星 · 2025-12-26
12月26日宏源药业（301246）龙虎榜数据：游资章盟主上榜
加载更多
公司概况
公司名称：
湖北省宏源药业科技股份有限公司
所属行业：
医药制造业
上市日期：
2023-03-20
主营业务：
湖北省宏源药业科技股份有限公司的主营业务是有机化学原料、医药中间体、原料药及医药制剂研发、生产和销售。公司的主要产品是乙二醛、乙醛酸、2-甲基-5-硝基咪唑、甲硝唑、鸟嘌呤及六氟磷酸锂等。
发行价格：
50.00
{"stockData":{"symbol":"301246","market":"SZ","secType":"STK","nameCN":"宏源药业","latestPrice":23.01,"timestamp":1774595019000,"preClose":21.91,"halted":0,"volume":37285090,"delay":0,"changeRate":0.0502,"floatShares":170000000,"shares":400000000,"eps":0.0356,"marketStatus":"已收盘","change":1.1,"latestTime":"03-27 15:00:00","open":21.21,"high":23.29,"low":21.21,"amount":849000000,"amplitude":0.0949,"askPrice":23.02,"askSize":2009,"bidPrice":23.01,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.0356,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"adjPreClose":21.91,"symbolType":"stock","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":24.1,"lowLimit":19.72,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":400006800,"isCdr":false,"pbRate":2.02,"roa":"--","peRate":646.348315,"roe":"--","epsLYR":0.1291,"committee":-0.626408,"marketValue":9204000000,"turnoverRate":0.2192,"status":0,"floatMarketCap":3913000000},"requestUrl":"/m/hq/s/301246","defaultTab":"news","newsList":[{"id":"2622887712","title":"宏源药业：6000吨/年产高纯晶体六氟磷酸锂改扩建项目正在建设中","url":"https://stock-news.laohu8.com/highlight/detail?id=2622887712","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622887712?lang=zh_cn&edition=full","pubTime":"2026-03-26 11:36","pubTimestamp":1774496170,"startTime":"0","endTime":"0","summary":"证券之星消息，宏源药业(301246)03月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司在罗田的六千吨每年的六氟磷酸锂改扩建项目预计二季度能投产吗？目前预计多久可以达产？宏源药业回复：您好！6000吨/年产高纯晶体六氟磷酸锂改扩建项目正在建设中，具体进展及完工投产时间，请关注公司的有关信息披露。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600018965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2620270350","title":"宏源药业（301246）1062.88万股限售股将于3月20日解禁，占总股本2.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620270350","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620270350?lang=zh_cn&edition=full","pubTime":"2026-03-20 08:01","pubTimestamp":1773964917,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，宏源药业于3月20日将有1062.88万股限售股份解禁，为公司首发原股东限售股份，占公司总股本2.66%。本次解禁后，公司还有2.3亿股限售股份，占总股本57.48%。宏源药业主营业务：有机化学原料、医药中间体、原料药、新能源及医药制剂的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000005894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2620473111","title":"宏源药业（301246）披露首次公开发行前部分股份上市流通提示性公告，3月17日股价下跌3.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620473111","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620473111?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:23","pubTimestamp":1773757396,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，宏源药业报收于21.01元，较前一交易日下跌3.76%，最新总市值为84.04亿元。公司于近日发布《关于首次公开发行前已发行部分股份上市流通提示性公告》。本次解除限售的股东为湖北省弘愿慈善基金会，解除限售股份数量为10,628,800股，占公司总股本的2.66%。限售期为自公司股票上市之日起36个月，上市流通日期为2026年3月20日。相关股东已履行股份锁定承诺，不存在违规占用资金或违规担保情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2619154115","title":"宏源药业（301246）披露关于使用部分超募资金及闲置募集资金进行现金管理的公告，3月13日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619154115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619154115?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:40","pubTimestamp":1773412832,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，宏源药业报收于21.8元，较前一交易日下跌1.0%，最新总市值为87.2亿元。该股当日开盘22.02元，最高22.68元，最低21.8元，成交额达3.35亿元，换手率为9.39%。公告显示，公司于2026年3月12日召开董事会，审议通过使用不超过16.00亿元超募资金及闲置募集资金进行现金管理的议案，期限自董事会审议通过之日起12个月内，资金可循环滚动使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300041874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2618292588","title":"宏源药业（301246）披露控股股东、实际控制人续签一致行动协议公告，3月11日股价上涨2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618292588","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618292588?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:15","pubTimestamp":1773238519,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，宏源药业报收于21.14元，较前一交易日上涨2.92%，最新总市值为84.56亿元。公司于2026年3月11日发布《关于控股股东、实际控制人续签一致行动协议的公告》。公告显示，湖北省宏源药业科技股份有限公司控股股东、实际控制人阎晓辉、尹国平、廖利萍于2026年3月10日续签《一致行动协议》，继续保持一致行动人关系，有效期为协议签署之日起十二个月，期满前30天无书面异议则自动续延十二个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2617839276","title":"宏源药业：公司的六氟磷酸锂产品生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2617839276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617839276?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:27","pubTimestamp":1772785631,"startTime":"0","endTime":"0","summary":"证券之星消息，宏源药业(301246)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司的六氟磷酸锂近几个月一直都是都是满产满消吗？宏源药业回复：您好，公司的六氟磷酸锂产品生产经营正常，具体情况请关注公司后续定期报告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600025939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2616378844","title":"股市必读：宏源药业（301246）今年截至3月3日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616378844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616378844?lang=zh_cn&edition=full","pubTime":"2026-03-04 01:47","pubTimestamp":1772560030,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，宏源药业报收于19.96元，下跌5.98%，换手率7.11%，成交量11.38万手，成交额2.33亿元。交易信息汇总股价提醒3月3日宏源药业收盘报19.96元，跌5.98%，当日成交1138.05万元。该股已连续2日下跌，当年累计跌幅20.04%。前10个交易日中，主力资金累计净流出7907.06万元，股价累计下跌8.99%；融资余额累计减少2606.83万元，融券余量累计增加5100股。资金流向3月3日主力资金净流出3406.29万元；游资资金净流入1360.89万元；散户资金净流入2045.4万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400000979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2610946410","title":"宏源药业跌2.66% 2023年上市即巅峰超募15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946410","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946410?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:24","pubTimestamp":1770888241,"startTime":"0","endTime":"0","summary":"中国经济网北京2月12日讯 宏源药业 今日收报21.20元，跌幅2.66%。该股目前处于破发状态。 宏源药业于2023年3月20日在深交所创业板上市，公开发行股票4,725.72万股，发行价格为50.00元/股，保荐机构为民生证券股份有限公司，保荐代表人为谢广化、肖继明。 宏源药业首次公开发行股票募集资金总额为人民币236,286.00万元，扣除发行费用后募集资金净额为219,584.37万元。 宏源药业首次公开发行股票的发行费用总额为16,701.63万元，其中保荐及承销费用13,931.96万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260212/32015256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2609030536","title":"宏源药业：目前公司现有六氟磷酸钠产品设计产能400吨/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2609030536","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609030536?lang=zh_cn&edition=full","pubTime":"2026-02-06 08:39","pubTimestamp":1770338350,"startTime":"0","endTime":"0","summary":"证券之星消息，宏源药业(301246)02月05日在投资者关系平台上答复投资者关心的问题。投资者提问：六氟磷酸钠的产能有多少，开工率是多少？宏源药业回复：您好，目前公司现有六氟磷酸钠产品设计产能400吨/年，产能利用率情况请关注公司后续定期报告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600007490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2609394360","title":"股市必读：宏源药业（301246）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609394360?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:41","pubTimestamp":1770226870,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，宏源药业报收于21.31元，上涨0.38%，换手率2.98%，成交量4.77万手，成交额1.01亿元。董秘最新回复投资者： 董秘你好，请问7000吨VC啥时候投产？VC，LIFSI等其他添加剂看起来更有上涨空间，请公司重视，未雨绸缪！董秘： 您好，公司年产7000吨VC添加剂项目正处于建设中，预计在2026年四季度可以投产，目前还没规划LIFSI等其他添加剂。当日关注点来自交易信息汇总：2月4日主力资金净流出700.68万元，散户资金净流入485.64万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2608135954","title":"宏源药业：年产7000吨VC添加剂项目正处于建设中","url":"https://stock-news.laohu8.com/highlight/detail?id=2608135954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608135954?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:39","pubTimestamp":1770194346,"startTime":"0","endTime":"0","summary":"证券之星消息，宏源药业02月04日在投资者关系平台上答复投资者关心的问题。VC，LIFSI等其他添加剂看起来更有上涨空间，请公司重视，未雨绸缪！宏源药业回复：您好，公司年产7000吨VC添加剂项目正处于建设中，预计在2026年四季度可以投产，目前还没规划LIFSI等其他添加剂。关于医药行业，公司已建立了较为完善的医药产业链，产品销往全球几十个国家和地区，与国内外知名制药企业建立了良好的合作关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400027444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2608814483","title":"宏源药业：六氟磷酸钠是钠电池的核心原材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2608814483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608814483?lang=zh_cn&edition=full","pubTime":"2026-02-03 08:51","pubTimestamp":1770079869,"startTime":"0","endTime":"0","summary":"证券之星消息，宏源药业(301246)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司打算提升六氟磷酸钠产能吗？如何看待未来3-5年钠电池的市场发展？宏源药业回复：您好，六氟磷酸钠是钠电池的核心原材料，随着六氟磷酸锂市场的好转，六氟磷酸钠价格优势凸显，未来将会根据六氟磷酸钠的市场行情变化进行规划，具体情况请关注公司的相关信息披露。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300007496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159796","BK0239","301246"],"gpt_icon":0},{"id":"2604111883","title":"宏源药业（301246）披露关于变更签字注册会计师的公告，01月20日股价下跌3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111883","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604111883?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:12","pubTimestamp":1768918344,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，宏源药业报收于21.83元，较前一交易日下跌3.87%，最新总市值为87.32亿元。公司于近日发布公告称，因中审众环会计师事务所内部工作调整，将公司2025年度财务报告及内部控制审计的签字注册会计师由原李维、彭冬梅变更为李维、方梦苑。方梦苑自2014年起从事上市公司审计，2012年起在中审众环执业，2025年开始为公司提供审计服务，近三年无签署上市公司审计报告记录，未受过监管处罚，符合独立性要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2604974922","title":"股市必读：宏源药业（301246）预计2025年全年归属净利润盈利1.13亿元至1.37亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604974922","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604974922?lang=zh_cn&edition=full","pubTime":"2026-01-19 03:11","pubTimestamp":1768763467,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，宏源药业报收于22.57元，上涨1.17%，换手率9.58%，成交量15.33万手，成交额3.44亿元。业绩披露要点业绩预告宏源药业发布业绩预告，预计2025年全年归属净利润盈利1.13亿元至1.37亿元；扣非后净利润预计盈利8200万元至1.06亿元。公司公告汇总2025年度业绩预告湖北省宏源药业科技股份有限公司预计2025年度归属于上市公司股东的净利润为11,300万元至13,700万元，同比增长119.57%至166.20%；扣除非经常性损益后的净利润为8,200万元至10,600万元，同比增长782.01%至1,040.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900001155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246"],"gpt_icon":0},{"id":"2603396762","title":"宏源药业(301246.SZ)发预增，预计2025年度归母净利润同比增长119.57%-166.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603396762","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603396762?lang=zh_cn&edition=full","pubTime":"2026-01-16 18:56","pubTimestamp":1768561017,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宏源药业(301246.SZ)发布2025年度业绩预告，预计全年实现归属于上市公司股东的净利润1.13亿元至1.37亿元，同比增长119.57%-166.20%。2025年度经营业绩预计较去年同期大幅上升，主要受六氟磷酸锂业务影响。报告期内，新能源车市场需求持续增长以及储能市场需求快速增长，公司六氟磷酸锂业务盈利能力显著改善。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宏源药业(301246.SZ)发预增，预计2025年度归母净利润同比增长119.57%-166.20%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301246"],"gpt_icon":0},{"id":"2601898414","title":"宏源药业跌4.44% 2023年上市即巅峰超募15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2601898414","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601898414?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:29","pubTimestamp":1767691752,"startTime":"0","endTime":"0","summary":"中国经济网北京1月6日讯 宏源药业 今日收报24.11元，跌幅4.44%。该股目前处于破发状态。 宏源药业于2023年3月20日在深交所创业板上市，公开发行股票4,725.72万股，发行价格为50.00元/股，保荐机构为民生证券股份有限公司，保荐代表人为谢广化、肖继明。 宏源药业首次公开发行股票募集资金总额为人民币236,286.00万元，扣除发行费用后募集资金净额为219,584.37万元。 宏源药业首次公开发行股票的发行费用总额为16,701.63万元，其中保荐及承销费用13,931.96万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260106/31919552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2600629480","title":"每周股票复盘：宏源药业（301246）因换手率上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2600629480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600629480?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:03","pubTimestamp":1767376991,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，宏源药业报收于25.0元，较上周的26.88元下跌6.99%。本周，宏源药业12月29日盘中最高价报26.5元。12月30日盘中最低价报22.05元。宏源药业当前最新总市值100.0亿元，在化学制药板块市值排名55/150，在两市A股市值排名1916/5181。本周关注点交易信息汇总：宏源药业因日换手率达30%登上龙虎榜，近5个交易日内第2次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2595866647","title":"12月29日宏源药业（301246）龙虎榜数据：游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2595866647","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595866647?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:38","pubTimestamp":1767001131,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年12月29日公布的交易公开信息显示，宏源药业因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年12月29日收盘，宏源药业报收于23.93元，下跌10.97%，换手率37.37%，成交量59.81万手，成交额14.42亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出1331.98万元，北向资金合计净买入4302.43万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900023827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2595028783","title":"宏源药业跌10.97% 2023年上市即巅峰超募15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2595028783","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595028783?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:59","pubTimestamp":1766998762,"startTime":"0","endTime":"0","summary":"中国经济网北京12月29日讯 宏源药业 今日收报23.93元，跌幅10.97%。该股目前处于破发状态。 宏源药业于2023年3月20日在深交所创业板上市，公开发行股票4,725.72万股，发行价格为50.00元/股，保荐机构为民生证券股份有限公司，保荐代表人为谢广化、肖继明。 宏源药业首次公开发行股票募集资金总额为人民币236,286.00万元，扣除发行费用后募集资金净额为219,584.37万元。 宏源药业首次公开发行股票的发行费用总额为16,701.63万元，其中保荐及承销费用13,931.96万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251229/31899727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2594260061","title":"12月26日宏源药业（301246）龙虎榜数据：游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2594260061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594260061?lang=zh_cn&edition=full","pubTime":"2025-12-26 17:47","pubTimestamp":1766742473,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年12月26日公布的交易公开信息显示，宏源药业因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年12月26日收盘，宏源药业报收于26.88元，上涨20.0%，涨停，换手率29.79%，成交量47.68万手，成交额12.16亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入2773.34万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600025913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774793847420,"stockEarnings":[{"period":"1week","weight":0.1448},{"period":"1month","weight":0.0245},{"period":"3month","weight":-0.144},{"period":"6month","weight":0.6204},{"period":"1year","weight":0.6397},{"period":"ytd","weight":-0.0796}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0126},{"period":"6month","weight":0.0224},{"period":"1year","weight":0.1601},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖北省宏源药业科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"28012人(较上一季度减少9.76%)","perCapita":"6071股","listingDate":"2023-03-20","address":"湖北省黄冈市罗田县凤山镇经济开发区宏源路8号","registeredCapital":"40000万元","survey":" 湖北省宏源药业科技股份有限公司的主营业务是有机化学原料、医药中间体、原料药及医药制剂研发、生产和销售。公司的主要产品是乙二醛、乙醛酸、2-甲基-5-硝基咪唑、甲硝唑、鸟嘌呤及六氟磷酸锂等。","listedPrice":50},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宏源药业(301246)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宏源药业(301246)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宏源药业,301246,宏源药业股票,宏源药业股票老虎,宏源药业股票老虎国际,宏源药业行情,宏源药业股票行情,宏源药业股价,宏源药业股市,宏源药业股票价格,宏源药业股票交易,宏源药业股票购买,宏源药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宏源药业(301246)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宏源药业(301246)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}